Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
CRVS
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
CRVS: Corvus Pharmaceuticals, Inc. Stock Analysis | finqOS
CRVS
$9.67
−3.40%
Lists
Call CRVS
Corvus Pharmaceuticals
CRVS
Back
Lists
Call CRVS
$9.67
−$0.34 · −3.40%
24/7
Overview
News
Down
33%
in three months and
16%
of the way up its 52-week range.
Call CRVS
Loading chart data...
Signal state